Drug manufacturer recalls Soltice Quick-RUB nationwide due to manufacturing deviations
Ecometics, Inc. recalled Soltice Quick-RUB nationwide due to Current Good Manufacturing Practice (CGMP) deviations. This was a voluntary recall initiated by the manufacturer in February 2023.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall without reported illnesses or injuries. The stated reason is manufacturing practice deviations, representing a precautionary voluntary recall without evidence of consumer harm.
Plain-English summary
Ecometics, Inc. initiated a nationwide recall of Soltice Quick-RUB, which contains menthol (5.1%) and camphor (5.1%), in response to Current Good Manufacturing Practice (CGMP) deviations. The product was distributed in two sizes: 1.33 oz (37g) plastic jars (approximately 23,993 units) and 3 oz (85g) plastic jars (approximately 34,284 units).
The recall was driven by manufacturing deviations identified at the production facility. The specific nature of these deviations is not disclosed in the FDA notice.
Consumers who purchased affected lots should stop using the product and contact their retailer or manufacturer for guidance. This was a voluntary recall initiated by the manufacturer in February 2023 and terminated in June 2023.
The recalled product
- Product
- Soltice Quick-RUB (Menthol 5.1%, Camphor 5.1%) packaged in a) 1.33 oz (37g) plastic jars and b) 3 Oz (85g) plastic jars
- Manufacturer
- Ecometics, Inc.
- Category
- Drug — Topical / OTC
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: a) 0E344A /AA
- exp. date N/A
- b) 2E243A
- Exp. Aug-25
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by Ecometics, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Ecometics, Inc.
See all →- HighSodium Fluoride Activator Concentrate Recalled for Manufacturing Practice Violations
FDA (Drugs) · 2023-08-30
- HighLugol's Strong Iodine Solution Recalled Due to Manufacturing Quality Deviations
FDA (Drugs) · 2023-08-30
- HighFDA Recalls AstrinGyn Surgical Hemostatic Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-08-30
- ModerateUnguentine Ointment Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-08-30
- HighYager's Liniment Recalled for Manufacturing Practice Violations
FDA (Drugs) · 2023-08-30
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- LowLupin Recalls Famotidine Oral Suspension Due to Manufacturing Deviations
FDA (Drugs) · 2017-09-13
- ModerateElroselabs Recalls Molleave OTC Product Due to cGMP Deviations
FDA (Drugs) · 2018-04-18
- ModerateMilbar Recalls Naturmetic Sunscreen Due to Manufacturing Deviations
FDA (Drugs) · 2018-05-23
- ModerateLupin Recalls Cefdinir Oral Suspension Due to CGMP Deviations
FDA (Drugs) · 2019-01-16
- ModerateElroselabs Recalls Conzerol Topical Cream Due to Manufacturing Deviations
FDA (Drugs) · 2018-04-18
- ModerateAcetaminophen Oral Suspension Recalled Due to Contaminated Raw Ingredient
FDA (Drugs) · 2021-11-17